Regenxbio Inc.
RGNX
Revenue
30.34M
▲604.00k▲2.03%
3 Months ChangeAssets
453.03M
▼-72.17M▼-13.74%
3 Months ChangeLiabilities
350.30M
▼-13.45M▼-3.70%
3 Months ChangeFree Cash Flow
32.61M
▲88.62M▲158.21%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-05
Form 8-K
ID: 0001193125-26-092566
2026-02-10
Form 8-K
ID: 0001193125-26-043342
2026-01-28
Form 8-K
ID: 0001193125-26-026139
2025-11-06
Form 8-K
ID: 0001193125-25-268101
2025-11-06
Form 10-Q
ID: 0001193125-25-268095
2025-08-18
Form 8-K
ID: 0000950170-25-109829
2025-08-07
Form 10-Q
ID: 0001193125-25-174953
2025-08-07
Form 8-K
ID: 0001193125-25-174947
2025-06-03
Form 8-K
ID: 0000950170-25-080986
2025-05-19
Form 8-K
ID: 0001193125-25-122456